Financial reports
10-Q
2018 Q3
Quarterly report
15 Nov 18
10-Q
2018 Q2
Quarterly report
14 Aug 18
10-Q
2018 Q1
Quarterly report
15 May 18
10-K
2017 FY
Annual report
23 Mar 18
10-Q
2017 Q3
Quarterly report
3 Nov 17
10-Q
2017 Q2
Quarterly report
11 Aug 17
10-Q
2017 Q1
Quarterly report
15 May 17
10-K
2016 FY
Annual report
30 Mar 17
10-Q
2016 Q3
Quarterly report
10 Nov 16
10-K/A
2015 FY
Annual report (amended)
16 Aug 16
Current reports
8-K
Aradigm Announces Effective Date of Modified Combined Chapter 11 Plan and Disclosure Statement
15 Jun 20
8-K
Other Events
4 Jun 20
8-K
Aradigm Announces Conditional Approval for the Combined Chapter 11 Plan and Disclosure Statement
30 Apr 20
8-K
Other Events
13 Apr 20
8-K
Other Events
3 Apr 20
8-K
Entry into a Material Definitive Agreement
9 Mar 20
8-K
Entry into a Material Definitive Agreement
21 Feb 20
8-K
Aradigm Announces Withdrawal of European Marketing Authorization Application (MAA) for Linhaliq
31 Oct 19
8-K
Aradigm Receives Feedback Following an Oral Explanation with the European Medicines Agency
21 Oct 19
8-K
Entry into a Material Definitive Agreement
10 Jun 19
Registration and prospectus
15-12B
Securities registration termination
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 20
Proxies
DEFA14A
Additional proxy soliciting materials
15 May 18
DEF 14A
Definitive proxy
15 May 18
PRE 14A
Preliminary proxy
1 May 18
DEFA14A
Additional proxy soliciting materials
19 Apr 17
DEF 14A
Definitive proxy
19 Apr 17
DEF 14A
Definitive proxy
16 May 16
PRE 14A
Preliminary proxy
6 May 16
DEFA14A
Additional proxy soliciting materials
19 Mar 15
DEF 14A
Definitive proxy
19 Mar 15
DEF 14A
Definitive proxy
28 Mar 14
Other
UPLOAD
Letter from SEC
23 Aug 16
CORRESP
Correspondence with SEC
16 Aug 16
UPLOAD
Letter from SEC
9 Aug 16
EFFECT
Notice of effectiveness
8 Jul 16
CORRESP
Correspondence with SEC
7 Jul 16
CORRESP
Correspondence with SEC
17 Jun 16
UPLOAD
Letter from SEC
9 Jun 16
EFFECT
Notice of effectiveness
8 Apr 15
EFFECT
Notice of effectiveness
8 Apr 15
EFFECT
Notice of effectiveness
21 Apr 14
Ownership
SC 13D
Aradigm Corp
5 Sep 19
3
Initial statement of insider ownership
5 Sep 19
4
Change in insider ownership
4 Sep 19
SC 13D/A
Aradigm Corp
4 Sep 19
4
Change in insider ownership
3 May 19
SC 13G/A
Aradigm Corp
14 Feb 19
4
Juergen Kurt Froehlich
5 Nov 18
4
Change in insider ownership
5 Nov 18
4
Juergen Kurt Froehlich
20 Sep 18
4
Theresa Matkovits
3 Jul 18